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Background: Currently, coronavirus COVID-19 has affected 210 countries around the world, killed more than 
268,500 and infected more than 3.8 million, according to worldometer, May 08, 2020. Home-care is especially 
important in these situations because hospitals are not seemingly safe during pandemic outbreaks. Also, the chance 
to get out of the home during the lockdown period is limited. Telemedicine and telehealth technologies are 
especially effective during epidemic outbreaks, when health authorities recommend implementing social distance 
systems.Materials and Methods: This study started in February 2020, when the Philippines reported its first death 
outside China. PubMed, ALTAVISTA, Embase, Scopus, the Science Web and the Cochrane Central Register have 
been carefully searched. The keywords were used to search out extensively followed journals from various 
publishers such as Elsevier, Springer, Willey Online Library, and Wolters Kluwer.Results: The idea of employing 
pharmacists in telemedicine is not only good for general patients’ healthcare access but also utilization of a huge 
number of pharmacists who are currently unemployed. In this Covid-19 pandemic situation, where vaccine and 
medicines are literally non-existent, this cheap but effective technology-based support can ensure maximum 
protection against virus spread and safety.But, Pharmacy education of Bangladesh does not meet the minimum 
requirement for adequate clinical, hospital and community pharmacy practice. The system needs special attention 
too.Conclusion: The telemedicine sector in Bangladesh is still in its beginning phase. Employing pharmacists with 
proper training would bring the best outcome but proper initiatives are not taken. The policy makers are the sole to 
take any initiatives in the country. Proper lobbing through proper channel is the only solution to establish 
pharmacists in telemedicine sector. 
Keywords: telemedicine; pharmacist’s intervention; tele-pharmacy challenges; healthcare situation in Bangladesh; 
underutilization of hospital pharmacy; pharmacy education; patient communication 
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Introduction 
Bangladesh's health care services are becoming 
unusually concentrated in a small fraction of costly 
critical health-demanding patients. A large part of these 
complex-patients suffers from multiple chronic 
diseases and are spending a lot of money.  
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Tele-pharmacy includes patient counselling, 
medication review and prescription review by a 
qualified pharmacist for the patients who are located at 
a far distance from the pharmacy.  
The most common way to use telemedicine is a 
responsive model, primarily physician-led with virtual 
visits stimulated by alerts using interactive services, 
which facilitates real-time interaction between the 
patient and provide.1It delivers resilience to services 
and enables pharmacists to work remotely, reducing 
the need for long journeys and increasing job 
satisfaction.2 The rise of pharmacists in epidemic 
situations has become increasingly popular in 
developed countries such as the United States, 
Australia, Canada and the United Kingdom. According 
to information from recent published articles in several 
ongoing journals, books, newsletters, magazines, etc., 
the duties, authority and responsibilities of pharmacists 
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are completely different from doctors and nurses, 
although there are some similarities. Along with 
doctors, pharmacists can serve as frontline healthcare 
workers during epidemics. The profession is developed 
and highly praised in both developed and 
underdeveloped countries. Millions of professional 
pharmacists worldwide work in various organizations, 
and according to data from the International 
Pharmaceutical Federation (FIP), nearly 75% of them 
work in patient care.3 Even in the United States, the 
continued lacking of primary health providers and 
medical specialists has made it possible for pharmacists 
to care for ambulatory patients with chronic diseases in 





Figure 1. District wise COVID-19 Infected Cases in Bangladesh (As of 23rd April, 2020, Source: 
corona.gov.bd) 
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Present Socio-Economic and Healthcare Situation 
Bangladesh is the seventh most populous country in the 
world and population of the country is expected to be 
nearly double by 2050, where communicable diseases 
are a major cause of death and disability.6,7 A recent 
Dengue outbreak in 2019, more than 100,000 people 
was affected in more than 50 districts in Bangladesh in 
the first 6 months of 2019.8,9 According to the 2018 
Country Environmental Analysis (CEA) report of the 
World Bank, particulate pollution causes the deaths of 
46,000 people in Bangladesh per year.10 Although a 
riverine country, 65% of the population in Bangladesh 
do not have access to clean water.11 Both surface water 
and groundwater sources are contaminated with 
different contaminants like toxic trace metals, 
coliforms as well as other organic and inorganic 
pollutants.5 Studies in capital Dhaka and Khulna also 
found that about 80% of fecal sludge from on-site pit 
latrines is not safely managed.12 Nearly half of all slum 
dwellers of the country live in Dhaka division and 35% 
of Dhaka's population are thought to live in slums.13,14 
A recent research demonstrates widespread poor 
hygiene and food-handling practices in restaurants and 
among food vendors.15 Less than 10% hospitals of this 
country follow the Medical Waste Management 
Policies.16 In 2017, 26 incidents of disease outbreak 
were investigated by National Rapid Response Team 
(NRRT) of IEDCR.17 Economic development and 
academic flourishment do not represent development in 
health sector. Out of the pocket treatment cost raised 
nearly 70% in the last decade.18 Although, officially 
80% of population has access to affordable essential 
drugs, there is plenty of evidence of a scarcity of 
essential drugs in government healthcare facilities.19 
Surprisingly, the country’s pharmaceutical sector is 
flourishing, exports grew by more than 7% in last 8 
months although total export earnings of the country 
drop to nearly 5%.20 In Bangladesh it has also been 
found that more than 80% of the population seeks care 
from untrained or inadequately trained village doctors 
and drug shop retailers.21 According to WHO, the 
current doctor-patient ratio in Bangladesh is only 5.26 
to 10,000, that places the country at second position 
from the bottom, among the South Asian countries.22 
According to World Bank data, Bangladesh has 8 
hospital beds for every 10,000 people; by way of 
comparison, the US has 29 while China has 42.23 
Tobacco is responsible for 1 in 5 deaths in Bangladesh, 
according to the WHO, kills more than 161,000 people 
on average every year. Around 85% population of age 
group 25-65 never checks for diabetes.24,25 
 
 
Pharmacy Education in Bangladesh 
Pharmacy Education in many developing countries, 
including Bangladesh, is still limited to didactic 
learning that produce theoretically ‘skilled’ 
professionals with degrees. Bangladesh's pharmacy 
curriculum does not meet the minimum requirement for 
adequate clinical, hospital and community pharmacy 
education because it is still linked to an old pharmacy 
model, e.g. based on chemistry and basic sciences. 
That is present curriculum produces Pharmacist only to 
work in the pharmaceutical industry and jobs in this 
field of work is going to be saturated. No university so 
far have modified their curriculum including topics as 
epidemiology, pharmaco-economics, clinical 
medicines, community skills. Manpower development 
for community pharmacies in Bangladesh is not 
systematically regulated and constitute an important 
public health issue. Three levels of pharmacy education 
currently offered in Bangladesh leading to either a 
university degree, a diploma or a certificate. Graduates 
with an industrial degree work while those with a 
diploma work in hospitals.26 Pharmacy is taught in 
about 100 public and private universities in Bangladesh 
and about 8000 pharmacy students graduate every 
year.27 Hospital, community and clinical pharmacy in 
Bangladesh have not been well developed due to lack 
of government policy.28 In real conditions of 
Bangladesh pharmacy practice areas for graduate 
pharmacist is limited in industry i.e., industrial 
pharmacy practices, in the marketing or regulatory 
sections. The educational system of pharmacy is one of 
the major reasons for bounded pharmacy practices 
because the courses included in bachelor degree 
principally emphasize on industrial practices.29 Over 
90% of B. Pharm curriculum stresses on product-
oriented expertise whereas only around 5% of the total 
course credits are assigned toward clinical pharmacy. 
his curricular framework indicates a minimum 
emphasis on patient care education.30 However, the 
graduates who pass out do not get employment easily 
due to their poor training, lack of in-depth knowledge 
of fundamental concepts and practical skills.17 
Consequently, skilled graduates leave for overseas 
where they find more prosperous jobs. Researchers 
argued that Pharmacy Education can be able to 
contribute for both public and private benefits if a 
realistic pattern is ensured on its operation.31 This 
system could be more favorable to the public if good 
hospital and community practices are formally 
introduced, as well as involving pharmacists and other 
qualified health care providers. 
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Present State of Pandemic Situation Handling by 
Bangladeshi Hospitals 
More than half of the 12,425 coronavirus cases 
detected in Bangladesh have been reported in the 
capital Dhaka.32,33 According to the government's 
disease control agency IEDCR, the virus hit a total of 
11 out of 64 districts in the country until 05.04.2020 
after first known cases were reported about a month 
ago.34 Amidst this global crisis, Bangladesh has been 
identified as one of the 25 most vulnerable countries to 
be affected by the fast-spreading virus. By 25.04. 2020, 
it was confirmed in 63 out of 64 districts.35 Many 
patients with fever, cold and breathing problems – 
which are also COVID-19 symptoms – have gone 
untreated as the hospitals in Dhaka are sending them to 
the IEDCR for coronavirus test.36 Many doctors do not 
provide services that fear the contagion and according 
to the patients, laboratory technicians shun workplaces 
stop medical tests. In some cases, serious patients who 
are not affected by COVID-19, moved from one 
hospital to the other but could not receive treatment 
and finally died, the media reported. In another case, 
the doctor fled leaving the patient behin.37-40 Doctors 
and other healthcare workers say they do not have 
adequate personal protective equipment and the health 
system cannot cope with the outbreak.41 Police have 
locked down a total 52 areas of Dhaka after Covid-19 
positive patients were found in the localities.42 Experts 
say elderly people infected with coronavirus need ICU 
support the most. The number of older persons in the 
country is over 0.8 million.43 The country's entire 
public health system has less than 450 ICU beds, only 
110 of which are outside the capital Dhaka.23 Country-
wise comparison shows that the country lacks far 
behind the other countries who are most at risk. The 
health minister on 29.03.2020 reported that there are 
only 500 ventilators in government hospitals and 700 
in private hospitals.35 Only a few hospitals dedicated 
for Covid-19 patients have a central oxygen storage 
system to supply continuous mechanical ventilation to 
ICU patients at a required pressure, including Dhaka 
Medical College Hospital, Bangabandhu Sheikh Mujib 
Medical University, Sir Salimullah Medical College 
Hospital, Square Hospitals, Apollo Hospital and Anwer 
Khan Modern Medical College Hospital, have that 
facility.44 
 
Under Utilization of Hospital Pharmacy 
The pharmacy profession is still lagging behind in 
developing countries as compared with developed 
countries in a way that the pharmacy professionals 
have never been considered as a part of health care 
team neither by the community nor by the health care 
providers. Although hospital pharmacists are 
recognized for its importance as health care provider in 
many developed countries, in most developing 
countries it is still underutilized or underestimated.45-48 
Hospital pharmacy practice is just started in some 
private modern hospitals in Bangladesh which is 
inaccessible for the majority of peoples due to high 
patients cost of these hospitals.49 People are totally 
unknown to the responsibilities of hospital pharmacist, 
even they don’t seek for recruit for hospital pharmacist 
in any hospital except a few aristocrat hospitals.50 A 
survey in Dhaka reported that 48% of respondents with 
symptoms of acute respiratory illness (ARI) identified 
local pharmacies as their first point of care. Licenses 
are provided to drug sellers by the Directorate General 
of Drug Administration when they have completed a 
grade C pharmacy degree (i.e. 3 months course) to 
legally dispense drugs but a grade A pharmacy degree 
holder, having a B. Pharm or Pharm. D degree should 
be more equipped to handle these situations, if trained 
properly. Knowledge and helpfulness of pharmacist 
were identified as two major determinants that could 
not only satisfy and but also promote willingness to 
pay for the service.51,52 They can individualize the 
medications and their dosing according to the needs of 
the patient, which can minimize the cost of care for the 
medication. In Bangladesh, however, graduate 
pharmacists do not engage directly in-patient care. 
Here, pharmacies in hospitals are primarily run by non-
clinically educated, diploma pharmacists.28 If the 
hospital pharmacy is established, patient care, proper 
dispensing of medications, and other patient-oriented 
issues can be handled properly. By maintaining a 
hospital pharmacy quality control program, the health 
sector can be enriched. 
 
Prospect of Pharmacists in Patient Management 
Service and Telehealth Care 
Pharmacists are the third largest healthcare 
professional group in the world after physicians and 
nurses.53 At present, Hospital Pharmacy has created 
enormous job opportunities, where graduate 
pharmacists play a vital role in patient rearing, 
rehabilitation and wellness. A professional pharmacist 
or a pharmacy apprentice at a clinic, hospital and 
community care can determine what to do in a given 
disease situation, if guided properly by another medical 
personnel.54-56 The country has a huge opportunity to 
recruit these pharmacists at Telehealth Care. In each 
call, a pharmacist can provide both appropriate and 
quality information from the most recent medical 
systems. Studies show that the lack of proper 
medication management leads to higher healthcare 
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costs, longer hospital stays, morbidity and mortality. 
Further, it was reported that one in every five 
hospitalizations was related to post-discharge 
complications and about seventy percent were related 
to proper use of the drug. In 2017, the World Health 
Organization committed to minimizing serious, 
avoidable drug-related harm over the next 5 years. 
Pharmacists' interventions to prevent drug-related 
problems at three community hospitals in California 
saved approximately 0.8 million USD in a year.57 The 
estimated annual cost of medication error-based 
illnesses and deaths worldwide was USD 500 billion 
due to non-compliance with the clinical intervention 
and quantities in 2016. Also, the authors estimate that 
more than 275,000 people die every year for the same 
reasons.58 A pharmacist can use simple and non-
medical terminology to set the goal for patients to 
understand the information as well as to fulfill the 
prescription by proper request. With chronic conditions 
such as cardiovascular and respiratory diseases, there is 
ample evidence of the effectiveness of the tele-
pharmacist for remote monitoring, communication and 
consultation.59 In addition, psychotherapy can also be 
operated through telehealth as part of behavioral 
health.60 Pandemic patient pharmacy needs have 
resemblances with the traditional patient population but 
with different focus.61 For example, when providing 
consulting services to patients, instead of focusing on 
medications as usual, their queries relate primarily to 
the knowledge of medical prevention and basic details 
on COVID-19, such as mask selection and standard 
COVID-19 signs and symptoms, symptomatic 
treatment options, breathing difficulties or cough 
management in comorbid situations, reinforcing 
behaviors that limit the spread of the pandemic, 
including social distancing and remaining in the home 
whenever possible through phone calls/video 
conferencing.62,63 Student pharmacists have earlier 
served as an effective educational resource for patients 
about the H1N1 pandemic.64 Overburdened by patient 
loads and the explosion of new drugs, physicians 
turned to pharmacists more and more for drug 
information, especially within institutional settings. 
They obtain medical and medication history, check 
medication errors including prescription, dispensing 
and administration errors, identify drug interactions, 
monitor ADR, suggest individualization of dosage 
regimen, provide patient counseling, etc.65 Among 
chronic disease patients, particularly those under 
quarantine, there is a greater challenge in the supply of 
drugs and compliance with medications, although the 
safety and effectiveness of care is still critical for these 
patients. Stronger data on the effectiveness of this area 
of pharmacy care, together with a critical assessment of 
its limitations, can raise awareness among the actors 
involved about its potential and could contribute to a 
wider dissemination of tele-pharmacy services in 
public interest. Sorwar et al, 2016 revealed that the 
existing telemedicine service reduced cost and travel 
time on average by 56% and 94% respectively 
compared to its counterpart conventional approach 
with high consumer satisfaction.66 
 
History of Telehealth Service in Bangladesh 
The year 1998 represents a milestone for eHealth in 
Bangladesh when the first eHealth project was 
introduced by Swinfen Charitable, a non-profit 
institution. It associated collaborative work between 
the Center for Paralyzed Rehabilitation (CRP) in 
Bangladesh and Haslar Royal Navy Hospital in the 
UK. In the same year the Ministry of Health and 
Family Welfare (MoHFW) launched its first initiative 
on eHealth.67 Just a year afterward the private 
enterprise Telemedicine Reference Center Limited 
(TRCL) started providing healthcare with mobile 
phones. The Bangladesh Telemedicine Association 
(BTA), a professional coalition, was created in 2001. 
That has provided a platform for ongoing and sparse 
eHealth initiatives in the country. A similar platform, 
called the Sustainable Development Network Program 
(SDNP), was formed in 2003 with the aim of 
establishing better cooperation and understanding 
between providers.68 Later in 2006, TRCL paired with 
GrameenPhone (GP) and established the Health 
Line:789 subscriber mobile help desk.69,70 A number of 
NGOs subsequently developed an interest in eHealth 
and mHealth, including BRAC, the Sajida Foundation 
and DNet.71 In addition, Bangladesh launched a toll-
free national emergency aid line 999 in December 2017 
to meet immediate needs in the event of any accident, 
crime, fire or ambulance.72 In addition, the IEDCR has 
launched 17 hotline numbers for the said Covid-19 
outbreak.73 
 
Challenges of Tele-pharmacy Implementation 
Firstly, it has limited evidence of its effectiveness 
beyond that of intervention by a traditional pharmacist. 
This favors the skepticism of both physicians and 
patients towards these services and limits their 
acceptance in the community.74 Second, the tele-
pharmacy is a service based on the technology. Thus, 
the driver is technology but also the limiting factor for 
its implementation. Establishing a tele-pharmacy 
service involves not only meeting technological 
requirements but also a considerable amount of time, 
effort and money.75 Third, effective tele-pharmacy 
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services should be based on standardized healthcare 
delivery models, and require appropriate regulations 
that may differ from country to country. For example, 
such facilities are not permitted or even restricted in 
some countries, while adequate legislation is available 
in others such as USA, Italy and other European 
countries.76-79 Unfortunately, despite the rampant 
potential of tele-pharmacy in many countries, the laws 
and policies governing pharmacy operations do not 
adequately address the growing sector. Fourthly, the 
reluctance or inability to use advanced technologies 
can limit the implementation of tele-pharmacy services 
from the perspective of both pharmacists and patients, 
especially in the context of the elderly.80-85 Fifthly, 
since tele-pharmacy involves the gathering, 
transmission and replacement of personal and health 
information on the web, information security and 
privacy are major issues. Data sharing of information 
collected via tele-pharmacy services with other 
healthcare professionals increases the possibility of 
security breaches. The security and integrity of patient 
data is therefore of paramount importance when 
determining the setup of a tele-pharmacy system of 
information technology.86-91 Sixth, the integration of 
tele-pharmacy services in the national healthcare 
systems and the connection of tele-pharmacy services 
(including a combination of electronic data entry, 
prescription order verification, online benefit 
adjudication, medication dispensing) among different 
areas of a country requires harmonizing the healthcare 
systems and related governing laws and setting up 
proper rules and regulations.92-94 Seventh, tele-
pharmacy services are not yet reimbursed: individuals 
are required to pay for these services, and the expenses 
are not covered by private or public health insurance.95-
99 This restricts the use of these services by patients 
who may eventually need them.  
 
Overcoming Challenges 
In Bangladesh a number of telemedicine systems were 
introduced. Telemedicine laws and reimbursement 
policies since telemedicine practice is increasing on a 
daily basis in Bangladesh, so structured laws and 
regulations on doctors, patient issues, licensing of 
physicians and telemedicine providers are very much 
needed. Clear rules should be in place on questions of 
reimbursement. Bangladesh Television (BTV) and 
other satellite channels can play an important part in 
popularizing telemedicine. They should broadcast 
successful cases considering telemedicine's efficacy 
and cost-efficiency. Telemedicine systems and services 
compatibility of hardware and software require users to 
have compatible hardware at both ends of the 
communications link, which reduces interoperability 
and the benefits of access to different sources of 
telemedicine expertise. If the equipment is difficult to 
access or are less likely to involve practitioners. 
Equipment for wireless telemedicine is preferable to 
wire devices. Telemedicine privacy and confidentiality 
involves the electronic transmission of patient medical 
records and information from one location to another 
via the Internet, or other computerized media. Medical 
information is often delicate, confidential and private. 
Telemedicine, thus presents significant challenges for 
safeguarding the privacy and confidentiality of 
information about patient health. Specific privacy 
regulations should govern the practice of telemedicine 
so that patients can feel safe in knowing that 
confidentiality of their personal information will have 
to suffer certain penalties. 
 
Conclusion 
Tele-pharmacy offers opportunity for highly trained 
clinical pharmacists to fill the needs of healthcare in 
both underserved and metropolitan environments. 
However, the article focuses two major issues public 
health support in pandemic situation. Firstly, 
importance of telemedicine in crisis moments of 
epidemic situation and credibility of pharmacists in this 
sector, both are apparently non-existent in Bangladesh. 
Structural training program should be arranged for the 
pharmacists before appointing in telemedicine. The 
concept will benefit around 70% rural people of 
Bangladesh, who has very limited access to healthcare 
facilities. At the end, it can be said that pharmacists can 
play a role in both medical aids and regulation. 
Similarly, in tele-healthcare, the professional 
pharmacist can play an essential role that has not been 
recognized yet due to lack of proper initiatives. We 
hope that policy makers of Bangladesh are aware of its 
potential and contribute to the wider promotion of tele-
pharmacy services in the interest of the citizenry.The 
article should provide healthcare associates and 
policymakers of Bangladesh a broader picture and 
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